Home » Topics » Regulatory » Patents

Patents
RSS

ViroPharma develops agents for HCV infection

Dec. 16, 1997

5-HT receptor (ant)agonists from Pfizer

Dec. 16, 1997

Natural anti-HIV agent disclosed by Hoechst

Dec. 16, 1997

Searle describes selective alphav/beta3 integrin antagonists

Dec. 16, 1997

Agents for HCV infection from ViroPharma

Dec. 11, 1997

3-Dimensional Pharmaceuticals discloses new serine protease inhibitors

Dec. 11, 1997

Protein farnesyltransferase inhibitors focus of research at Merck & Co.

Dec. 11, 1997

CRF antagonists from DuPont Merck for anxiety, depression and related disorders

Dec. 9, 1997

Alteon prepares new AGE inhibitors

Dec. 9, 1997

Byk Gulden presents new PDE IV inhibitors

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...